Grazoprevir plus elbasvir and other treatment options in hepatitis C infected patients with stage 4-5 chronic kidney disease

Research output: Contribution to journalEditorial

Original languageEnglish (US)
Article numberS13
JournalAnnals of Translational Medicine
Volume4
DOIs
StatePublished - Oct 1 2016

ASJC Scopus subject areas

  • Medicine(all)

Cite this